Glucosamine/Chondroitin OA Long-Term Efficacy Not Known - JAMA Article
This article was originally published in The Tan Sheet
Executive Summary
The long-term efficacy and toxicity of popular supplement ingredients glucosamine and chondroitin for treatment of osteoarthritis (OA) symptoms has not been established, Tanveer Towheed, MD, and Tassos Anastassiades, MD, Queen's University, Kingston, Ontario, state in an editorial published in the March 15 issue of the Journal of the American Medical Association.
You may also be interested in...
NCCAM Sponsoring First Glucosamine/Chondroitin Sulfate Multicenter Study
NCCAM is sponsoring the first U.S. multicenter study investigating the "short-term (16 weeks) effectiveness of glucosamine and chondroitin sulfate in reducing pain and improving function in a large number of patients with osteoarthritis of the knee," the National Institutes of Health National Center for Complementary & Alternative Medicine announced.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands